Table 2.
Anti-malarial drugs prescribed to hospitalized children with positive malaria test results
| Anti-malarial type | Hospital | |||||
|---|---|---|---|---|---|---|
| Tororo (n = 7291) (%) | Jinja (n = 9085) (%) | Kambuga (n = 998) (%) | Mubende (n = 4077) (%) | Apac (n = 3832) (%) | Kabale (N = 200) (%) | |
| IV quinine | 6404 (87.8) | 7162 (78.8) | 842 (84.4) | 3513 (86.2) | 2842 (74.2) | 105 (52.5) |
| IV artesunate | 457 (6.3) | 1578 (17.4) | 112 (11.2) | 239 (5.9) | 915 (23.9) | 66 (33.3) |
| IM artemether | 336 (4.6) | 262 (2.9) | 10 (1.0) | 141 (3.5) | 5 (0.1) | 7 (3.5) |
| Oral artemether–lumefantrine | 87 (1.2) | 59 (0.6) | 12 (1.2) | 125 (3.1) | 55 (1.4) | 17 (8.5) |
| Oral quinine | 3 (0.04) | 16 (0.2) | 18 (1.8) | 54 (1.3) | 8 (0.2) | 3 (1.5) |
| Rectal artesunate | 2 (0.03) | 1 (0.01) | 4 (0.4) | 2 (0.04) | 7 (0.2) | 1 (0.5) |
| Oral sulfadoxine–pyrimethamine | 1 (0.01) | 4 (0.04) | 0 | 2 (0.04) | 0 | 1 (0.5) |
| Oral artesunate | 1 (0.01) | 3 (0.03) | 0 | 0 | 0 | 0 |
| Oral chloroquine | 0 | 0 | 0 | 1 (0.02) | 0 | 0 |